Suppr超能文献

131I SPECT/CT在分化型甲状腺癌患者管理中的增量价值。

Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.

作者信息

Chen Libo, Luo Quanyong, Shen Yan, Yu Yongli, Yuan Zhibin, Lu Hankui, Zhu Ruisen

机构信息

Department of Nuclear Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.

出版信息

J Nucl Med. 2008 Dec;49(12):1952-7. doi: 10.2967/jnumed.108.052399. Epub 2008 Nov 7.

Abstract

UNLABELLED

(131)I whole-body scintigraphy (WBS) is a highly sensitive method for the detection of differentiated thyroid tumors and metastases. However, a lack of anatomic landmarks and the physiologic accumulation of the tracer complicate interpretation of the images. This prospective study was designed to evaluate the incremental value of (131)I SPECT/CT over planar WBS in the management of patients with differentiated thyroid carcinoma (DTC).

METHODS

Planar imaging was performed on 66 consecutive DTC patients who were considered to have locally advanced or metastatic disease after total or nearly total thyroidectomy. SPECT/CT was added for patients whose planar findings were inconclusive. The planar images were interpreted by 2 experienced nuclear medicine physicians. Interpretation of the SPECT/CT images was a consensus opinion of one of the nuclear medicine physicians and an experienced radiologist. Fusion images were considered to improve image interpretation when they better localized sites of increased (131)I uptake. The final diagnosis was verified by pathologic findings, other imaging modalities, and clinical follow-up. Both site-based and patient-based analyses were performed, and the impact of SPECT/CT results on therapeutic strategy was assessed.

RESULTS

A total of 232 foci were observed by (131)I WBS, including 33.2% of foci localized in the thyroid bed, 62.1% due to malignant lesions, and 4.7% caused by nonthyroidal physiologic or benign uptake or a contaminant. Overall, 37 SPECT/CT studies were performed on 23 patients, whose planar images showed 81 inconclusive lesions. Precise localization and characterization of (131)I-avid foci were achieved through (131)I SPECT/CT in 69 (85.2%) and 67 (82.7%) of the 81 foci, respectively. Fusion images were considered to be of benefit in 17 (73.9%) of 23 patients. The therapeutic strategy was changed in 8 (47.1%) of 17 patients. Uncommon metastatic lesions were found in 9 (13.6%) of 66 patients with regard to SPECT/CT fusion images.

CONCLUSION

Fusion of SPECT and CT images was of incremental value over WBS in increasing diagnostic accuracy, reducing pitfalls, and modifying therapeutic strategies in 73.9% of DTC patients. As SPECT/CT techniques emerge, (131)I SPECT/CT may demonstrate higher value than WBS in the management of DTC.

摘要

未标记

碘-131全身闪烁扫描(WBS)是检测分化型甲状腺肿瘤及转移灶的一种高灵敏度方法。然而,缺乏解剖标志以及示踪剂的生理性聚集使图像解读变得复杂。本前瞻性研究旨在评估碘-131单光子发射计算机断层扫描/计算机断层扫描(SPECT/CT)相对于平面WBS在分化型甲状腺癌(DTC)患者管理中的附加价值。

方法

对66例连续性DTC患者进行平面成像,这些患者在全甲状腺切除或近全甲状腺切除术后被认为有局部晚期或转移性疾病。对于平面检查结果不明确的患者加做SPECT/CT。平面图像由2名经验丰富的核医学医师解读。SPECT/CT图像的解读是1名核医学医师和1名经验丰富的放射科医师的共识意见。当融合图像能更好地定位碘-131摄取增加部位时,认为其有助于图像解读。最终诊断通过病理结果、其他影像学检查及临床随访得以证实。进行了基于部位和基于患者的分析,并评估了SPECT/CT结果对治疗策略的影响。

结果

碘-131 WBS共观察到232个病灶,其中33.2%的病灶位于甲状腺床,62.1%为恶性病变,4.7%由非甲状腺生理性摄取、良性摄取或污染物引起。总体而言,对23例患者进行了37次SPECT/CT检查,这些患者的平面图像显示有81个不明确病变。通过碘-131 SPECT/CT分别对81个病灶中的69个(85.2%)和67个(82.7%)实现了碘-131摄取灶的精确定位和特征描述。23例患者中有17例(73.9%)认为融合图像有益。17例患者中有8例(47.1%)的治疗策略发生了改变。根据SPECT/CT融合图像,66例患者中有9例(13.6%)发现了罕见转移灶。

结论

在提高诊断准确性、减少陷阱以及改变73.9%的DTC患者的治疗策略方面,SPECT与CT图像融合相对于WBS具有附加价值。随着SPECT/CT技术的出现,碘-131 SPECT/CT在DTC管理中可能显示出比WBS更高的价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验